John Donofrio Jr. - Aug 11, 2023 Form 4 Insider Report for AYTU BIOPHARMA, INC (AYTU)

Role
Director
Signature
/s/ Josh Disbrow as attorney-in-fact for John Donofrio, Jr.
Stock symbol
AYTU
Transactions as of
Aug 11, 2023
Transactions value $
$0
Form type
4
Date filed
8/15/2023, 07:39 PM
Previous filing
Dec 23, 2022
Next filing
Nov 8, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AYTU Common Shares Award $0 +1.5K +196.85% $0.00 2.26K Aug 11, 2023 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Grant of restricted shares, which vest as follows: 1/3 on August 11, 2024, with the remaining restricted shares vesting in eight equal installments every three months beginning on November 11, 2024.
F2 Reflects 1-for-20 reverse stock split effected by the Issuer on January 6, 2023.